BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,000 | +109423.8% | 118,000 | +10.3% | 0.01% | +16.7% |
| Q2 2023 | $105 | +1.0% | 107,000 | +5.9% | 0.01% | 0.0% |
| Q1 2023 | $104 | -2.8% | 101,000 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $107 | -99.9% | 101,000 | +16.1% | 0.01% | +16.7% |
| Q3 2022 | $86,000 | +26.5% | 87,000 | +26.1% | 0.01% | +20.0% |
| Q2 2022 | $68,000 | -1.4% | 69,000 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $69,000 | +30.2% | 69,000 | +35.3% | 0.00% | +33.3% |
| Q4 2021 | $53,000 | +6.0% | 51,000 | +4.1% | 0.00% | -40.0% |
| Q3 2021 | $50,000 | – | 49,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |